Releases
Found 315 articles
Team Cookie Scores Double Win at 25th Asia-Pacific PR Awards
Seoul-based consultancy Team Cookie secured two honors at the 25th Asia-Pacific PR Awards in Hong Kong, marking the agency's third consecutive year of international recognition. With wins in the B2B and Public Education categories, the firm emerged as the most-awarded Korean entity at this year’s ceremony.
VeriTrade Wins Best Matching Engine at 2026 TradingTech Insight Awards
The 2026 TradingTech Insight US Awards have named VeriTrade the Best Matching Engine for Exchanges and Electronic Trading Venues. The recognition highlights the platform's ability to maintain deterministic performance and ultra-low latency, a critical requirement for modern financial markets transitioning toward continuous, round-the-clock operations.
Vermiculus Wins Top Matching Engine Award at TradingTech Insight 2026
VeriTrade, the core matching engine developed by Swedish firm Vermiculus, has secured the top honor for Best Matching Engine for Exchanges and Electronic Trading Venues at the 2026 TradingTech Insight US Awards. The win highlights the platform's role in supporting the industry's shift toward continuous, round-the-clock market operations.
XPENG X9 Outperforms Rivals in World’s Largest EV Range Test
The XPENG X9 has secured a double victory at the 2026 NAF El Prix, outstripping all 24 competing vehicles in both real-world range efficiency and charging speed. The seven-seater demonstrated a 11.4% positive deviation from its official WLTP range, proving its endurance on the road under rigorous, independent conditions.
TeamViewer Retains Gartner Leader Status for Third Consecutive Year
Gartner has named TeamViewer a Leader in its 2026 Magic Quadrant for Digital Employee Experience Management Tools, marking the company’s third consecutive year in the top tier. The recognition underscores a strategic pivot toward predictive, AI-driven resolution capabilities designed to automate enterprise IT management at scale.
Acousia Therapeutics Reports Positive Phase 2a Results for ACOU085
In a study of testicular cancer patients undergoing chemotherapy, the experimental drug ACOU085 successfully mitigated hearing loss caused by cisplatin. The Phase 2a PROHEAR trial indicates that the small molecule, administered via transtympanic injection, provides a protective effect against the damage typically inflicted on the inner ear during standard cancer treatments.
Rock Tech Lithium Expands European Reach With Xetra Listing
Rock Tech Lithium has officially brought its shares to Xetra, the electronic trading platform operated by Deutsche Börse. This move aims to bridge the gap between the Canadian mining company and European institutional investors, serving as a precursor to a planned listing on the NASDAQ stock exchange.
Volta Labs Automates Twist Bioscience Fast Hybridization Workflow
Volta Labs has integrated the Twist Fast Hybridization Kit into its Callisto sample preparation system, enabling laboratories to transition from traditional overnight target enrichment to a fully automated, same-day workflow. This development marks the expansion of Twist’s hybrid capture portfolio on the digital fluidics platform.
Duni Group Warns of Q2 Earnings Miss Amid German Logistics Crisis
A botched warehouse transition to a new logistics hub in Meppen, Germany, has triggered a sharp downturn for Duni Group. The company now expects second-quarter operating income to miss market projections by 50 to 70 million SEK, as delivery failures and rising costs plague its supply chain operations.
Daribatech Secures Ministry of Finance Approval for UAE E-Invoicing
With the January 2027 deadline for the national e-invoicing mandate approaching, Dubai-based Daribatech has secured pre-approved status as an Accredited Service Provider (ASP) from the UAE Ministry of Finance. This authorization allows the firm to assist businesses in navigating the transition to mandatory structured XML invoice reporting.
Simcere Pharmaceutical Partners with Stanford to Combat Pulmonary Fibrosis
Simcere Pharmaceutical has signed a research agreement with Stanford Medicine to develop novel therapies for idiopathic pulmonary fibrosis. The collaboration targets a first-in-class molecule, granting the Shanghai-based company full global rights to the resulting product upon successful completion of exploratory research conducted by Stanford’s chemical biology laboratories.
Borussia Dortmund and CSTS Partner to Expand Chinese Fan Engagement
Borussia Dortmund is deepening its footprint in Mainland China through a new strategic collaboration with CSTS Enterprises. By leveraging the Generation C initiative, the German club aims to bring its iconic mascot, EMMA, and its signature football culture directly to local supporters through youth programs and regional tour activations.
Dofo Tea Reimagines Centuries-Old Rituals for Modern Kitchens
In Chaozhou, the ancestral home of Teochew Gongfu Tea, Dofo Tea has unveiled a top-to-bottom packaging redesign aimed at demystifying China’s complex tea culture. The brand, led by third-generation artisan Xu Jiahua, is trading traditional exclusivity for a tactile, color-coded experience designed to integrate seamlessly into the daily routines of global consumers.
Simcere Pharmaceutical Partners with Stanford to Combat Pulmonary Fibrosis
Simcere Pharmaceutical has signed a research agreement with Stanford Medicine to develop a first-in-class molecule targeting idiopathic pulmonary fibrosis. The collaboration aims to address a condition that currently limits patient survival to a median of three years, leveraging specialized expertise from Stanford’s chemical biology laboratories.
ION XTP Central Limits Named Top Pre-Trade Risk Provider in USA
ION has secured the "Best Pre-Trade Risk Controls Provider" title at the 2026 TradingTech Insight Awards in the USA. The win highlights the firm's XTP Central Limits platform, which replaces fragmented, spreadsheet-based risk management with a unified, automated dashboard for capital markets participants across North America.
AbbVie Reports Nine-Year Outcomes for Venetoclax in CLL Treatment
Patients with previously untreated chronic lymphocytic leukemia saw sustained benefits from a fixed-duration regimen of venetoclax and obinutuzumab, according to nine-year results from the Phase 3 CLL14 trial presented at the European Hematology Association 2026 Congress in Stockholm.
Pope John XXIII Regional High School Joins Empowered Series
A national spotlight on Catholic education is set to air as Pope John XXIII Regional High School partners with the documentary series Empowered, hosted by Meg Ryan. The segment examines how the New Jersey institution navigates the intersection of traditional faith-based values and the demands of a modern, technology-driven academic landscape.
Tiryaki Syria Partners with Sovereign Fund to Boost Agricultural Output
A new industrial hub in Syria will process 400,000 tonnes of oilseeds annually under a strategic agreement between Tiryaki Syria and the Syrian Sovereign Fund. The ten-year partnership aims to bolster national food security while generating an estimated 500 million dollars in annual production value for the local economy.
Phinomics Unlocks Circular DNA Secrets on All Access with Andy Garcia
While the linear, X-shaped chromosome has long defined our understanding of genetics, a hidden world of circular DNA remains tucked inside our cells. The documentary series All Access hosted by Andy Garcia is now turning its lens toward Phinomics, a biotech group mapping these elusive structures to reshape modern medicine.
AbbVie Reports Nine-Year Outcomes for Venetoclax in CLL Treatment
Patients with previously untreated chronic lymphocytic leukemia (CLL) showed sustained long-term benefits from a fixed-duration regimen of venetoclax combined with obinutuzumab, according to final data from the Phase 3 CLL14 trial presented at the European Hematology Association 2026 Congress in Stockholm.
China Approves Akeso’s Gumokimab for Plaque Psoriasis
China’s National Medical Products Administration has approved gumokimab, an anti-IL-17 monoclonal antibody developed by Akeso, for the treatment of moderate-to-severe plaque psoriasis. The regulatory nod follows clinical data showing the drug achieves superior skin clearance rates compared to existing therapeutic options while requiring a significantly reduced annual injection schedule.
Roblox Faces Securities Class Action Lawsuit After Revenue Miss
Investors who purchased Roblox Corporation securities are facing a critical deadline as a class action lawsuit moves forward against the gaming company. The litigation follows a sharp 18% decline in the stock price triggered by the company's disclosure of reduced revenue guidance and slowing engagement metrics earlier this year.
Cars.com Appoints Sarah Kettler as Chief Marketing Officer
Chicago-based marketplace Cars.com has awarded 86,540 restricted stock units to Sarah Kettler, the company’s newly appointed Chief Marketing Officer. The grant serves as a material inducement for her hiring, which officially took effect on June 1, 2026, following approval from the firm’s compensation committee.
Luffa Launches PolyMind to Shift Prediction Markets Toward Social Gaming
Luffa has launched the open beta of PolyMind, a social-first forecasting application designed to strip away the high-frequency trading dominance typical of traditional prediction markets. By integrating directly into chat interfaces, the platform aims to replace Wall Street-style speculation with community-driven, peer-to-peer event forecasting.
Enliven Therapeutics Secures $400 Million in Upsized Public Offering
Burlingame-based Enliven Therapeutics has priced an upsized public offering of common stock and pre-funded warrants, aiming to raise approximately $400 million. The clinical-stage biopharmaceutical firm is issuing over 8.9 million shares at $37.50 each to accelerate its development of small molecule precision medicine therapies.
GCL SI Targets Niche Solar Markets with Scenario-Specific Technology
At the SNEC 2026 exhibition in Shanghai, GCL System Integration showcased a pivot toward specialized photovoltaic applications. Moving beyond simple scale, the company introduced a suite of modules engineered for distinct environments, ranging from typhoon-prone coastal zones and high-altitude deserts to commercial rooftops requiring enhanced dust mitigation.
Vantage Earns Spot on Fortune Crypto Innovators List
Vantage has been named to the Fortune Crypto Innovators list, marking a bridge between traditional multi-asset brokerage and the expanding digital currency sector. The inclusion recognizes the firm's role in providing a unified infrastructure for traders navigating both conventional markets like forex and emerging digital asset ecosystems.
Bulgaria Launches Major 150 MW Battery Storage Facility in Nova Zagora
A 150 MW / 600 MWh battery storage facility has officially commenced operations in Nova Zagora, marking a significant step in Bulgaria’s efforts to stabilize its power grid. Developed by Enery and built by Sungrow and Sunotec, the site represents one of the largest utility-scale energy storage projects in Southeast Europe.
Hisense Brings RGB MiniLED Tech to FIFA World Cup 2026 Stage
A week-long fan experience at New York’s Hudson Yards marks the official start of Hisense’s FIFA World Cup 2026 activation. The consumer electronics giant is leveraging its status as a tournament sponsor to showcase its latest display innovations while blending stadium-inspired interactive zones with professional football culture.
Shanghai launches 200 nighttime events to boost summer economy
Under the theme "Beyond Expectation," Shanghai has kicked off its 2026 Tonight series, transforming the city’s commercial hubs, waterfronts, and parks into vibrant after-dark destinations. The campaign coordinates nearly 200 events, integrating major sporting festivals, cultural exhibitions, and retail promotions to sustain the city's status as a top-tier nightlife market.